[18F]fluorodeoxyglucose positron emission tomography/computed tomography in combination with clinical data in predicting overall survival in non-small-cell lung cancer patients: A retrospective study

被引:0
|
作者
Cegla, P. [1 ]
Currie, G. M. [2 ]
Cholewinski, W. [1 ,3 ]
Bryl, M. [4 ,5 ]
Trojanowski, M. [6 ]
Matuszewski, K. [7 ]
Piotrowski, T. [3 ,7 ]
Czepczynski, R. [8 ,9 ]
机构
[1] Greater Poland Canc Ctr, Dept Nucl Med, Garbary 15, PL-61866 Poznan, Poland
[2] Charles Sturt Univ, Sch Dent & Hlth Sci, Wagga Wagga, Australia
[3] Poznan Univ Med Sci, Dept Electroradiol, Poznan, Poland
[4] Poznan Univ Med Sci, Reg Ctr Lung Dis Poznan, Oncol Dept, Poznan, Poland
[5] Poznan Univ Med Sci, Dept Thorac Surg, Poznan, Poland
[6] Greater Poland Canc Ctr, Greater Poland Canc Registry, Poznan, Poland
[7] Greater Poland Canc Ctr, Dept Med Phys, Poznan, Poland
[8] Affidea Poznan, Dept Nucl Med, Poznan, Poland
[9] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Dis, Poznan, Poland
关键词
Positron emission tomography; Computed tomography; Neural network; Lung cancer; Survival; TOTAL LESION GLYCOLYSIS; F-18 FDG PET/CT; PROGNOSTIC VALUE; ARTIFICIAL-INTELLIGENCE; NEURAL-NETWORKS; PARAMETERS;
D O I
10.1016/j.radi.2024.04.004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Positron emission tomography/computed tomography (PET/CT) has an established role in evaluating patients with lung cancer. The aim of this work was to assess the predictive capability of [ 18 F] Fluorodeoxyglucose ([ 18 F]FDG) PET/CT parameters on overall survival (OS) in lung cancer patients using an arti ficial neural network (ANN) in parallel with conventional statistical analysis. Methods: Retrospective analysis was performed on a group of 165 lung cancer patients (98M, 67F). PET features associated with the primary tumor: maximum and mean standardized uptake value (SUV max , SUV mean ), total lesion glycolysis (TLG) metabolic tumor volume (MTV) and area under the curvecumulative SUV histogram (AUC-CSH) and metastatic lesions (SUV maxtotal , SUV meantotal , TLG total , and MTV total ) were evaluated. In parallel with conventional statistical analysis (Chi -Square analysis for nominal data, Student's t test for continuous data), the data was evaluated using an ANN. There were 97 input variables in 165 patients using a binary classi fication of either below, or greater than/equal to median survival post primary diagnosis. Additionally, phantom study was performed to assess the most optimal contouring method. Results: Males had statistically higher SUV max (mean: 10.7 vs 8.9; p = 0.020), MTV (mean: 66.5 cm 3 vs. 21.5 cm 3 ; p = 0.001), TLG (mean 404.7 vs. 115.0; p = 0.003), TLG total (mean: 946.7 vs. 433.3; p = 0.014) and MTV total (mean: 242.0 cm 3 vs. 103.7 cm 3 ; p = 0.027) than females. The ANN after training and validation was optimised with a final architecture of 4 scaling layer inputs (TLG total , SUV maxtotal , SUVmeantotal and disease stage) and receiving operator characteristic (ROC) analysis demonstrated an AUC of 0.764 (sensitivity of 92.3%, speci ficity of 57.1%). Conclusion: Conventional statistical analysis and the ANN provided concordant findings in relation to variables that predict decreased survival. The ANN provided a weighted algorithm of the 4 key features to predict decreased survival. Implication for practice: Identi fication of parameters which can predict survival in lung cancer patients might be helpful in choosing the group of patients who require closer look during the follow-up. (c) 2024 Published by Elsevier Ltd on behalf of The College of Radiographers.
引用
收藏
页码:971 / 977
页数:7
相关论文
共 50 条
  • [1] Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer:: A prospective study
    Kalff, V
    Hicks, RJ
    MacManus, MP
    Binns, DS
    McKenzie, AF
    Ware, RE
    Hogg, A
    Ball, DL
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) : 111 - 118
  • [2] Use of [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography after Curative Treatment of Non-Small-Cell Lung Cancer Patients: A Nationwide Cohort Study
    Guldbrandsen, Kasper Foged
    Sopina, Liza
    Rasmussen, Torben Riis
    Fischer, Barbara Malene
    DIAGNOSTICS, 2024, 14 (02)
  • [3] 18F-fluorodeoxyglucose positron emission tomography/computed tomography for predicting prognosis of small cell lung cancer patients
    Chen, X.
    Shen, L.
    Hong, Y.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2023, 21 (02): : 211 - 215
  • [4] [18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer
    Sasaki, R
    Komaki, R
    Macapinlac, H
    Erasmus, J
    Allen, P
    Forster, K
    Putnam, JB
    Herbst, RS
    Moran, CA
    Podoloff, DA
    Roth, JA
    Cox, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1136 - 1143
  • [5] A MODELING FRAMEWORK FOR THE ASSESSMENT OF [(18)F]-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN PREDICTING OVERALL SURVIVAL IN NON-SMALL CELL LUNG CANCER
    Suleiman, Ahmed A.
    Frechen, Sebastian
    Scheffler, Matthias
    Zander, Thomas
    Wolf, Juergen
    Nogova, Lucia
    Fuhr, Uwe
    DRUG METABOLISM REVIEWS, 2014, 45 : 229 - 229
  • [6] Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients
    Wu, Yihua
    Li, Peiwei
    Zhang, Honghe
    Shi, Yu
    Wu, Han
    Zhang, Jinjie
    Qian, Yufeng
    Li, Chao
    Yang, Jun
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (02) : E37 - E47
  • [7] Mediastinal staging in non-small-cell lung carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography
    Stefan Walbom Harders
    Hans Henrik Madsen
    Karin Hjorthaug
    Anne Kirstine Arveschoug
    Torben Riis Rasmussen
    Peter Meldgaard
    Johanne Andersen Hoejbjerg
    Hans Kristian Pilegaard
    Henrik Hager
    Michael Rehling
    Finn Rasmussen
    Cancer Imaging, 14
  • [8] Mediastinal staging in non-small-cell lung carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography
    Harders, Stefan Walbom
    Madsen, Hans Henrik
    Hjorthaug, Karin
    Arveschoug, Anne Kirstine
    Rasmussen, Torben Riis
    Meldgaard, Peter
    Hoejbjerg, Johanne Andersen
    Pilegaard, Hans Kristian
    Hager, Henrik
    Rehling, Michael
    Rasmussen, Finn
    CANCER IMAGING, 2014, 14
  • [9] Early [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic non-small cell lung cancer (NSCLC).
    Helissey, Carole
    Metivier, Denis
    Rousseau, Claire
    Gontier, Eric
    Vedrine, Lionel
    Ceccaldi, Bernard
    Ferrand, Francois-Regis
    Bonardel, Gerald
    Le Moulec, Sylvestre
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer
    Mostafa, Rehab
    Abdelsamie Kandeel, Ahmed
    Abd Elkareem, Maha
    Nardo, Lorenzo
    Abdelhafez, Yasser G.
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (05) : 540 - 548